Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153118539> ?p ?o ?g. }
- W2153118539 endingPage "31" @default.
- W2153118539 startingPage "22" @default.
- W2153118539 abstract "Novel drugs for Erectile Dysfunction (ED) must be assessed for their interactions with other already approved medications that are processed through similar metabolic pathways. The cytochrome P450 enzyme family, in particular 3A4 isoform, is ubiquitously used to oxidize azole antifungals, erythromycin, and HIV protease inhibitors. Administering multiple medications using cytochrome P450 CYP3A4 (3A4) as a primary metabolic route may cause unexpected toxicological effects in patients. Current U.S Food and Drug Administration (FDA) approved ED drugs such as sildenafil (Viagra), tadalafil (Levitra), and vardenafil (Cialis), all Phosphodiesterase-5 inhibitors, are also metabolized by 3A4. The overlapping metabolic pathways for the above mentioned PDE-5 inhibitors are known, however it is still imperative to discover any negative clinical manifestations that may arise from their concomitant use or their use with other substrates that are metabolized by 3A4 enzyme. Worldwide, approximately 150 million men are struggling with ED, making this research a valid obligation. Consequently, interaction of the widely prescribed ED drugs and their interactions with 3A4 enzyme are discussed in this review. Key words: Cytochrome P450, 3A4, erectile dysfunction, Viagra, Cialis, Levitra." @default.
- W2153118539 created "2016-06-24" @default.
- W2153118539 creator A5001294853 @default.
- W2153118539 creator A5007756672 @default.
- W2153118539 creator A5015505896 @default.
- W2153118539 creator A5033394491 @default.
- W2153118539 creator A5045753376 @default.
- W2153118539 creator A5058140644 @default.
- W2153118539 creator A5061775591 @default.
- W2153118539 creator A5062402834 @default.
- W2153118539 creator A5083802933 @default.
- W2153118539 date "2011-02-01" @default.
- W2153118539 modified "2023-09-25" @default.
- W2153118539 title "Pharmacokinetic drug interactions of phosphodiesterase-5 inhibitors mediated by cytochrome P450 3A4 isoform" @default.
- W2153118539 cites W1008149269 @default.
- W2153118539 cites W150607669 @default.
- W2153118539 cites W1576608716 @default.
- W2153118539 cites W1936422345 @default.
- W2153118539 cites W1956875558 @default.
- W2153118539 cites W1970093780 @default.
- W2153118539 cites W1976294230 @default.
- W2153118539 cites W1976337335 @default.
- W2153118539 cites W1984339345 @default.
- W2153118539 cites W1992585792 @default.
- W2153118539 cites W1995285957 @default.
- W2153118539 cites W1995496266 @default.
- W2153118539 cites W2003222087 @default.
- W2153118539 cites W2010379871 @default.
- W2153118539 cites W2024273387 @default.
- W2153118539 cites W2027006196 @default.
- W2153118539 cites W2030169887 @default.
- W2153118539 cites W2030581072 @default.
- W2153118539 cites W2048622432 @default.
- W2153118539 cites W2049245722 @default.
- W2153118539 cites W2055698659 @default.
- W2153118539 cites W2067145171 @default.
- W2153118539 cites W2068913937 @default.
- W2153118539 cites W2069127863 @default.
- W2153118539 cites W2072698115 @default.
- W2153118539 cites W2077206342 @default.
- W2153118539 cites W2082354493 @default.
- W2153118539 cites W2084257654 @default.
- W2153118539 cites W2084978991 @default.
- W2153118539 cites W2087329318 @default.
- W2153118539 cites W2088130312 @default.
- W2153118539 cites W2097502628 @default.
- W2153118539 cites W2098105917 @default.
- W2153118539 cites W2106195907 @default.
- W2153118539 cites W2110980033 @default.
- W2153118539 cites W2118163167 @default.
- W2153118539 cites W2121939064 @default.
- W2153118539 cites W2127587525 @default.
- W2153118539 cites W2131020156 @default.
- W2153118539 cites W2139177217 @default.
- W2153118539 cites W2143539434 @default.
- W2153118539 cites W2145445529 @default.
- W2153118539 cites W2148012276 @default.
- W2153118539 cites W2158478351 @default.
- W2153118539 cites W2159885935 @default.
- W2153118539 cites W2162887308 @default.
- W2153118539 cites W2163656952 @default.
- W2153118539 cites W2004437999 @default.
- W2153118539 doi "https://doi.org/10.5897/ijmms.9000173" @default.
- W2153118539 hasPublicationYear "2011" @default.
- W2153118539 type Work @default.
- W2153118539 sameAs 2153118539 @default.
- W2153118539 citedByCount "0" @default.
- W2153118539 crossrefType "journal-article" @default.
- W2153118539 hasAuthorship W2153118539A5001294853 @default.
- W2153118539 hasAuthorship W2153118539A5007756672 @default.
- W2153118539 hasAuthorship W2153118539A5015505896 @default.
- W2153118539 hasAuthorship W2153118539A5033394491 @default.
- W2153118539 hasAuthorship W2153118539A5045753376 @default.
- W2153118539 hasAuthorship W2153118539A5058140644 @default.
- W2153118539 hasAuthorship W2153118539A5061775591 @default.
- W2153118539 hasAuthorship W2153118539A5062402834 @default.
- W2153118539 hasAuthorship W2153118539A5083802933 @default.
- W2153118539 hasConcept C109650736 @default.
- W2153118539 hasConcept C112705442 @default.
- W2153118539 hasConcept C126322002 @default.
- W2153118539 hasConcept C16005928 @default.
- W2153118539 hasConcept C2776768464 @default.
- W2153118539 hasConcept C2778822586 @default.
- W2153118539 hasConcept C2779548794 @default.
- W2153118539 hasConcept C2779929075 @default.
- W2153118539 hasConcept C2780035454 @default.
- W2153118539 hasConcept C2780315139 @default.
- W2153118539 hasConcept C2780816001 @default.
- W2153118539 hasConcept C33664856 @default.
- W2153118539 hasConcept C526171541 @default.
- W2153118539 hasConcept C62231903 @default.
- W2153118539 hasConcept C71924100 @default.
- W2153118539 hasConcept C74534348 @default.
- W2153118539 hasConcept C98274493 @default.
- W2153118539 hasConceptScore W2153118539C109650736 @default.
- W2153118539 hasConceptScore W2153118539C112705442 @default.
- W2153118539 hasConceptScore W2153118539C126322002 @default.
- W2153118539 hasConceptScore W2153118539C16005928 @default.